Assuta Medical Center

The trials here

What the 10 trials at this site are about, from their registry records.

Conditions

• Follicular lymphoma2 trials
• Obesity2 trials
• Chronic lymphocytic leukaemia1 trial
• Diffuse large B-cell lymphoma1 trial
• Fatty liver disease (MASLD/MASH)1 trial
• Lung cancer1 trial
• Myeloproliferative neoplasms1 trial
• Pancreatic cancer1 trial

Phase

• Phase 35 trials
• Phase 21 trial

Status

• Active, not recruiting4 trials
• Completed4 trials
• Recruiting2 trials

Lead sponsor

• BeOne Medicines2 trials
• Ariel University1 trial
• Assuta Medical Center1 trial
• Eli Lilly and Company1 trial
• Genesis Medical AI1 trial
• and 4 more

Running trials

• Recruiting

  A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

  NCT07165028· Phase 3· Eli Lilly and Company· Source

  Contact: Ziv Ben Ari (principal investigator)

• Recruiting

  Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera

  NCT06093672· Phase 3· Italfarmaco· Source

  Contact: Maurizio Caserini

• Active, not recruiting

  Study of Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Obinutuzumab in Participants With Chronic Lymphocytic Leukemia (CLL)

  NCT06073821· Phase 3· BeOne Medicines· Source

• Active, not recruiting

  A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma

  NCT05100862· Phase 3· BeOne Medicines· Source

• Active, not recruiting

  Stereotactic MRI-guided On-table Adaptive Radiation Therapy (SMART) for Locally Advanced Pancreatic Cancer

  NCT03621644· Viewray Inc.· Source

• Active, not recruiting

  Selinexor (KPT-330) in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

  NCT02227251· Phase 2· Karyopharm Therapeutics Inc· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Fatty liver disease (MASLD/MASH)1 recruiting
• Myeloproliferative neoplasms1 recruiting

Closed trials

• Completed

  Nutritional Therapy to Incretin-based Anti-obesity Medications in the Management of Gastrointestinal Adverse Events

  NCT06431308· Ariel University· Source

• Completed

  Clinical Evaluation of the Lung Cancer AI-based Decision Support Tool in Low-Dose Lung CT

  NCT07052773· Genesis Medical AI· Source

• Completed

  Remote Intervention for Weight Regain After Sleeve Gastrectomy

  NCT05122013· Assuta Medical Center· Source

• Completed

  Study of Ibrutinib and Rituximab in Treatment Naïve Follicular Lymphoma

  NCT02947347· Phase 3· Pharmacyclics LLC.· Source